Literature DB >> 22610785

Reciprocal induction between α-synuclein and β-amyloid in adult rat neurons.

Shohreh Majd1, Fariba Chegini, Tim Chataway, Xin-Fu Zhou, Weiping Gai.   

Abstract

In spite of definite roles for β-amyloid (Aβ) in familial Alzheimer's disease (AD), the cause of sporadic AD remains unknown. Amyloid senile plaques and Lewy body pathology frequently coexist in neocortical and hippocampal regions of AD and Parkinson's diseases. However, the relationship between Aβ and α-synuclein (α-Syn), the principle components in the pathological structures, in neuronal toxicity and the mechanisms of their interaction are not well studied. As Aβ and α-Syn accumulate in aging patients, the biological functions and toxicity of these polypeptides in the aging brain may be different from those in young brain. We examined the neurotoxicity influences of Aβ1-42 or α-Syn on mature neurons and the effects of Aβ1-42 or α-Syn on the production of endogenous α-Syn or Aβ1-40 reciprocally using a model of culture enriched with primary neurons from the hippocampus of adult rats. Treatment of neurons with high concentrations of Aβ1-42 or α-Syn caused significant apoptosis of neurons. Following Aβ1-42 treatment at sub apoptotic concentrations, both intra- and extra-cellular α-Syn levels were significantly increased. Reciprocally, the non-toxic levels of α-Syn treatment also increased intra- and extra-cellular Aβ1-40 levels. The phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, suppressed α-Syn-induced Aβ1-40 elevation, as well as Aβ1-42-induced α-Syn elevation. Thus, high concentrations of Aβ1-42 and α-Syn exert toxic effects on mature neurons; however, non-toxic concentration treatment of these polypeptides induced the production of each other reciprocally with possible involvement of PI3K pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610785     DOI: 10.1007/s12640-012-9330-y

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  53 in total

1.  Fibrillar beta-amyloid (Abeta) (1-42) elevates extracellular Abeta in cultured hippocampal neurons of adult rats.

Authors:  Shohreh Majd; Karim Rastegar; Asadollah Zarifkar; Mohammad Ali Takhshid
Journal:  Brain Res       Date:  2007-09-25       Impact factor: 3.252

Review 2.  Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies.

Authors:  Daniel D Christensen
Journal:  CNS Spectr       Date:  2007-02       Impact factor: 3.790

3.  Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody.

Authors:  S Yu; X Li; G Liu; J Han; C Zhang; Y Li; S Xu; C Liu; Y Gao; H Yang; K Uéda; P Chan
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

4.  Imaging amyloid deposition in Lewy body diseases.

Authors:  S N Gomperts; D M Rentz; E Moran; J A Becker; J J Locascio; W E Klunk; C A Mathis; D R Elmaleh; T Shoup; A J Fischman; B T Hyman; J H Growdon; K A Johnson
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

5.  Isolation and culture of adult rat hippocampal neurons.

Authors:  G J Brewer
Journal:  J Neurosci Methods       Date:  1997-02       Impact factor: 2.390

6.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

7.  Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.

Authors:  Gwendolyn T Wong; Denise Manfra; Frederique M Poulet; Qi Zhang; Hubert Josien; Thomas Bara; Laura Engstrom; Maria Pinzon-Ortiz; Jay S Fine; Hu-Jung J Lee; Lili Zhang; Guy A Higgins; Eric M Parker
Journal:  J Biol Chem       Date:  2004-01-06       Impact factor: 5.157

8.  Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.

Authors:  Takuma Okada; Masaki Wakabayashi; Keisuke Ikeda; Katsumi Matsuzaki
Journal:  J Mol Biol       Date:  2007-05-31       Impact factor: 5.469

9.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Authors:  K Uéda; H Fukushima; E Masliah; Y Xia; A Iwai; M Yoshimoto; D A Otero; J Kondo; Y Ihara; T Saitoh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

Review 10.  Aggregation and neurotoxicity of alpha-synuclein and related peptides.

Authors:  O M A el-Agnaf; G B Irvine
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

View more
  7 in total

1.  APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.

Authors:  Mahua Maulik; Kyle Peake; JiYun Chung; Yanlin Wang; Jean E Vance; Satyabrata Kar
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

Review 2.  Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.

Authors:  Md Sahab Uddin; Anna Stachowiak; Abdullah Al Mamun; Nikolay T Tzvetkov; Shinya Takeda; Atanas G Atanasov; Leandro B Bergantin; Mohamed M Abdel-Daim; Adrian M Stankiewicz
Journal:  Front Aging Neurosci       Date:  2018-01-30       Impact factor: 5.750

3.  α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.

Authors:  Hazel L Roberts; Bernard L Schneider; David R Brown
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

Review 4.  The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.

Authors:  Liying Yang; Hongyan Wang; Lijun Liu; Anmu Xie
Journal:  Front Neurosci       Date:  2018-02-20       Impact factor: 4.677

5.  Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses.

Authors:  Nicholas G Norwitz; Adrian Soto Mota; Sam G Norwitz; Kieran Clarke
Journal:  Front Aging Neurosci       Date:  2019-07-31       Impact factor: 5.750

Review 6.  Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.

Authors:  Shohreh Majd; John H Power; Hugh J M Grantham
Journal:  BMC Neurosci       Date:  2015-10-23       Impact factor: 3.288

Review 7.  Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities.

Authors:  Naomi P Visanji; Anthony E Lang; Gabor G Kovacs
Journal:  Transl Neurodegener       Date:  2019-09-04       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.